Retrospective Study
Copyright ©The Author(s) 2021.
World J Gastrointest Surg. Sep 27, 2021; 13(9): 1000-1011
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.1000
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 CONSORT diagram. Inclusion of patients.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Oncological outcomes according to the status of adjuvant chemotherapy in patients with ypT0–1 rectal cancer after preoperative chemoradiotherapy. A: Recurrence-free survival; B: Overall survival. ACTx: Adjuvant chemotherapy.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Oncological outcomes according to the status of adjuvant chemotherapy by the type of surgery. A: Recurrence-free survival (RFS) in patients treated with radical resection; B: Overall survival (OS) in patients who underwent radical resection; C: RFS in local excision (LE); D: OS in patients who underwent LE. ACTx: Adjuvant chemotherapy.